| 视网膜静脉阻塞继发黄斑水肿患者黄斑中心凹下脉络膜厚度变化研究 |
| |
| 引用本文： | 舒娜,姜波,史春生. 视网膜静脉阻塞继发黄斑水肿患者黄斑中心凹下脉络膜厚度变化研究[J]. 眼科新进展, 2021, 0(2): 154-157. DOI: 10.13389/j.cnki.rao.2021.0032 |
| |
| 作者姓名： | 舒娜 姜波 史春生 |
| |
| 作者单位： | 230041 安徽省合肥市，安徽省第二人民医院中古友谊眼科中心 |
| |
| 摘 要： | 目的 研究视网膜中央静脉阻塞（central retinal vein occlusion，CRVO）和视网膜分支静脉阻塞（branch retinal vein occlusion，BRVO）继发黄斑水肿(ME)患者黄斑中心凹下脉络膜厚度(subfoveal choroidal thickness，SFCT)的变化情况，并探讨单次玻璃体内注射康柏西普后的短期反应。方法 回顾性病例对照研究。选取2019年6月至2020年6月在我院接受治疗的31例视网膜静脉阻塞继发ME的初治患者，根据发病类型分为CRVO组（16例16眼）和BRVO组（15例15眼）。所有患者在确诊后均接受玻璃体内注射康柏西普治疗。分别在康柏西普注射前和注射后2周测量两组SFCT并比较。结果 CRVO组注射前患眼的SFCT为（319.73±19.28）μm，较对侧健眼［（255.13±16.15）μm］明显增厚，差异有统计学意义(P=0.000)；注射后2周患眼的SFCT迅速降为（283.33±21.61）μm,与注射前相比差异具有统计学意义(P=0.000)。BRVO组注射前患眼SFCT为（310.31±19.41）μm，较对侧健眼［（255.31±21.69）μm］明显增厚；注射后2周患眼的SFCT迅速下降为（266.56±16.30）μm，与注射前相比差异具有统计学意义(P=0.000)。康柏西普注射前后CRVO组患眼和BRVO组患眼之间的SFCT变化值差异无统计学意义(P=0.210)。结论 CRVO和BRVO继发ME患眼的SFCT均明显比对侧健眼增厚，并在玻璃体内注射康柏西普后短时间内明显变薄。
|
| 关 键 词： | 黄斑中心凹下脉络膜厚度 视网膜静脉阻塞 黄斑水肿 康柏西普 |
Changes in subfoveal choroidal thickness in eyes with macular edema secondary to retinal vein occlusion |
| |
| SHU Na,JIANG Bo,SHI Chunsheng. Changes in subfoveal choroidal thickness in eyes with macular edema secondary to retinal vein occlusion[J]. Recent Advances in Ophthalmology, 2021, 0(2): 154-157. DOI: 10.13389/j.cnki.rao.2021.0032 |
| |
| Authors: | SHU Na JIANG Bo SHI Chunsheng |
| |
| Affiliation: | Department of Ophthalmology,Anhui No.2 Provincial People’s Hospital,Hefei 230041,Anhui Province,China |
| |
| Abstract: | Objective To investigate the changes in subfoveal choroidal thickness (SFCT) in patients with macular edema (ME) secondary to branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO), and to investigate the short-term response to a single intravitreal injection of conbercept.Methods The retrospective case-control studies were performed. A total of 31 patients with RVO secondary to ME who were initially treated in our hospital from June 2019 to June 2020 were randomly selected and divided into the CRVO group (16 patients 16 eyes) and the BRVO group (15 patients 15 eyes) according to the incidence type. All patients received conbercept intravitreal injection. SFCT was measured before and 2 weeks after conbercept injection. Paired t test was performed to compare the SFCT of RVO eyes and fellow eyes, as well as the SFCT of pre-injection and post-injection. Independent t test was performed to compare the SFCT of BRVO eyes and CRVO eyes.Results In the CRVO patients, the SFCT of the eye before injection was (319.73±19.28) μm, which was significantly thickened compared with that of the contralateral eye ［(255.13±16.15) μm］, with statistically significant difference (P=0.000). Two weeks after injection, the SFCT of the affected eye rapidly decreased to (288.33±21.61)μm, and the difference was statistically significant (P=0.000). In BRVO patients, the SFCT of the affected eye before injection was (310.31±19.41)μm, which was significantly thickened compared with that of the contralateral eye ［(255.31±21.69)μm］. Two weeks after injection, the SFCT of the affected eyes decreased rapidly to (266.56±16.30)μm, and the difference was statistically significant (P=0.000). There was no significant difference in SFCT changes between the CRVO group and the BRVO group before and after the conbercept injection (P=0.210).Conclusion The SFCT of CRVO and BRVO secondary ME patients is significantly thicker than that of contralateral healthy eyes, and is significantly reduced in a short time after combercept injection. |
| |
| Keywords: | subfoveal choroidal thickness retinal vein occlusion macular edema conbercept |
|
| 点击此处可从《眼科新进展》浏览原始摘要信息 |
|
点击此处可从《眼科新进展》下载免费的PDF全文 |
